Swiss Commercial Services Stock News

SIG Group (SWX:SIGN) has named Mikko Keto as its next Chief Executive Officer, drawing attention across the market. His background in driving business transformation and operational change has investors looking closely at what this could mean for SIG’s direction. See our latest analysis for SIG Group. The announcement of Mikko Keto’s appointment sparked a surge in SIG Group’s share price, jumping over 11% in the past week alone. While that burst of optimism stands out, it follows a...

Partners Group Holding (SWX:PGHN) has named Nicholas Smith Wang as Partner and Co-Head of its Private Equity Technology Vertical. This move underscores the firm's focus on expanding its technology investment capabilities with experienced senior leadership. See our latest analysis for Partners Group Holding. Partners Group's appointment of Nicholas Smith Wang comes at a time when momentum around the stock has been mixed. The company’s 1-year total shareholder return stands at -24.6%, signaling...

One of the biggest stories of last week was how ams-OSRAM AG ( VTX:AMS ) shares plunged 23% in the week since its...

Barry Callebaut (SWX:BARN) stock came into focus after Goldman Sachs initiated coverage with a Buy rating, signaling increased attention from market participants. This move suggests broader confidence in the company’s mid-term prospects and ongoing transformation. See our latest analysis for Barry Callebaut. Momentum has started to build for Barry Callebaut, with its strategic partnership with NotCo AI and a recently affirmed dividend highlighting its transformation agenda. While the 90-day...

Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...

On November 18, 2025, u-blox Holding AG (SWX:UBXN) was removed from the S&P Global BMI Index, a widely tracked global benchmark for equities. This index exclusion can influence trading behavior, as passive funds often adjust their portfolios to align with index changes, potentially impacting liquidity. We'll now consider how the index removal and subsequent fund adjustments may shape u-blox Holding's broader investment narrative. We've found 15 US stocks that are forecast to pay a dividend...

Key Insights Given the large stake in the stock by institutions, Landis+Gyr Group's stock price might be vulnerable to...

Galderma recently presented new clinical data from its Restylane and Sculptra portfolios at the American Society for Dermatologic Surgery 2025 Annual Meeting in Chicago, including results that supported the recent FDA approval of Restylane Lyft for chin augmentation in adults. This new data not only highlights high patient satisfaction and durable results for the company’s injectable aesthetics but also addresses emerging needs among patients experiencing facial changes following...

The last three months have been tough on ARYZTA AG ( VTX:ARYN ) shareholders, who have seen the share price decline a...

Barry Callebaut announced a collaboration with NotCo AI to integrate artificial intelligence into chocolate recipe development, combining Barry Callebaut’s expertise with NotCo’s proprietary AI platform to accelerate innovation and address sector challenges. This partnership signals a shift toward digital transformation in the chocolate industry, aiming to create more tailored, sustainable, and efficient solutions at scale. We’ll now explore how Barry Callebaut’s move into AI-powered...

Ypsomed Holding AG recently reported results for the half year ended September 30, 2025, revealing net income of CHF 139.09 million, up from CHF 32.6 million a year earlier, with basic and diluted earnings per share rising to CHF 10.19 from CHF 2.39. This sharp increase in profitability highlights the company's growing efficiency and operational momentum over the last year. With net income rising to CHF 139.09 million, we'll consider how this earnings surge influences Ypsomed Holding's...

Shareholders might have noticed that Swiss Re AG ( VTX:SREN ) filed its third-quarter result this time last week. The...

Adecco Group AG recently reported its third quarter 2025 earnings, showing sales of €5.78 billion and net income of €89 million, alongside updated guidance for revenue growth and the announcement that Valentina Ficaio will become CFO in January 2026, succeeding Coram Williams. While Adecco experienced slightly improved sales year-on-year, continued pressure on net income and changes in financial leadership could influence its medium-term operational and strategic direction. We’ll explore how...

Earlier this month, SKAN Group AG issued a profit warning for 2025 after a portfolio review revealed several project delays, resulting in lowered earnings and sales guidance for the current financial year. Despite the near-term challenges, SKAN reiterated its medium-term targets and highlighted a robust order intake that is expected to drive a strong rebound in 2026. We’ll examine how SKAN’s revised 2025 outlook and order backlog developments impact the longer-term investment case for the...

There wouldn't be many who think Sunrise Communications AG's ( VTX:SUNN ) price-to-sales (or "P/S") ratio of 1x is...

Ypsomed Holding AG ( VTX:YPSN ), is not the largest company out there, but it received a lot of attention from a...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...

Sonova Holding AG's ( VTX:SOON ) price-to-earnings (or "P/E") ratio of 23.2x might make it look like a sell right now...

With a median price-to-earnings (or "P/E") ratio of close to 20x in Switzerland, you could be forgiven for feeling...

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") above 20x, you may consider...

In recent days, Barclays upgraded Givaudan SA from Equalweight to Overweight, citing an improved structural growth outlook as well as an expanded focus on local and regional customers and high-growth markets, while other major analysts updated their ratings as well. Barclays specifically pointed to multi-year opportunities in natural colors reformulation in North America and highlighted that concerns over a potential sharp slowdown in Fine Fragrance may be exaggerated, supporting the...

Montana Aerospace reported third quarter and nine-month 2025 earnings, posting sales of €250.11 million and €718.79 million respectively, with a net loss for the period despite strong operational growth and the company's transition to a pure-play aerospace business following divestments. While the company showed increased revenue and a reduced net loss year-on-year, its significant downward revision of 2025 financial guidance stood out against positive business transformation and backlog...

Sandoz Group AG recently announced a global license agreement with EirGenix Inc. to commercialize a proposed biosimilar of pertuzumab, a key oncology medicine for HER2-positive breast cancer, granting Sandoz exclusive rights in most global markets with a total consideration of up to US$152 million in milestone payments. This agreement further deepens Sandoz’s existing collaboration with EirGenix, expanding its biosimilar oncology portfolio and enhancing its position to access an estimated...